Health Check: Like bloodthirsty sharks, offshore acquirers are circling cheap biotech assets
Road safety tech ‘missing’ from Aussie cars
Biocurious: Dimerix could be riding big and beautiful kidney drug success earlier than expected
Top 10 at 11: ASX jumps on open as copper and battery metals rally
Billionaire winners and losers: Who made and lost money in the 2025 financial year?
China’s dominance of the gallium market is near total – but there’s opportunity for Western disruptors
‘Very positive for the gas industry’: Omega’s Trevor Brown on ADNOC’s Santos bid
ASX June Winners: ASX 200 rose 1.4pc in June, up nearly 10pc for quarter
Break it Down: Trigg takes in $12.5m strategic backing for North American antimony
Explorers Podcast: Albion sees gold value in Yandal West greenstone
Contributors
Our Resident Experts
Mining
Explorers Podcast: Albion sees gold value in Yandal West greenstone
Explorers Podcast: Norm Seckold on uncovering Uvre’s New Zealand gold projects
Resources Top 5: Sunrise Energy Metals fills scandium war chest after oversubscribed SPP
Resources Top 5: Institutional investors attracted to Koonenberry’s golden success
Kristie Batten: Koonenberry Gold sees shades of De Grey success story at Sunnyside
Featured in Mining
Tech
ASX Tech June Winners: Defence tech stocks dominate record-breaking month
The four AI tools everyday Aussies are using to clock off sooner
AI ‘havoc’ warning: expert calls for radical solution
Xero aims to crack US market by buying accounting platform Melio Payments
BlackRock calls defence tech the next theme to watch as NATO shifts into rearm mode
Featured in Tech
Health & Biotech
Biocurious: Dimerix could be riding big and beautiful kidney drug success earlier than expected
Health Check: And the EOFY biotech winner is … gasp … a pot stock
Dr Boreham’s Crucible: ‘Better not louder’, Audeara is tuned in to the global audiology market
Health Check: Tetratherix breaks biotech IPO drought with 13pc gain on debut
Health Check: Paradigm makes scenic acquisitive detour, but it’s no strategic shift
Featured in Health & Biotech
Experts
Why investors buy stocks at record prices
Criterion: Virgin’s trumphant float means more IPOs should be cleared for take-off
Stock Tips: Expert eyes are on WiseTech and Santos this week
The ‘outlandish’ property schemes hurting homebuyers
Is it time to move on from ‘old gold’ defensive strategies?
The four traits of successful investors
Broker Upgrades: WA gold developer becomes Canaccord’s latest ‘spec buy’
